News & Analysis as of

Life Sciences Financing Venture Capital

Fenwick & West LLP

Reflections on the J.P. Morgan Healthcare Conference: Key Themes for 2024

Fenwick & West LLP on

The Fenwick life sciences team recently returned from the 2024 JP Morgan Healthcare conference. As we reflect back on the week, there were several key themes and trends that we expect will continue to resonate and evolve over...more

McDermott Will & Emery

Innovation in Financing: Where Are We Seeing Growth?

McDermott Will & Emery on

Meanwhile, cash-strapped biotechs have in many cases been forced to leverage relationships with big pharma to address liquidity. Cash is king in a financing environment such as we have observed over the last 18 months, and...more

Hogan Lovells

Strategic financial options for clinical stage life sciences companies in a troubled equity market

Hogan Lovells on

Early 2023 has seen new and unprecedented financial challenges for clinical stage life sciences companies. The financing rounds of 2021 and 2022 are starting to run off, while at the same time the equity markets are either...more

Allen Matkins

Life Sciences Real Estate Update - 2.08.23

Allen Matkins on

Last year’s solid venture capital investment in life sciences was, as expected, focused on the big three markets of San Diego, Boston, and San Francisco. But as a recent Cushman & Wakefield report found, emerging markets saw...more

Fenwick & West LLP

Silicon Valley Venture Capital Survey – Third Quarter 2022

Fenwick & West LLP on

Our survey analyzed the terms of 196 venture financings closed in the third quarter of 2022 by companies headquartered in Silicon Valley. Summary - The number of venture financings in Silicon Valley remained stable...more

Orrick, Herrington & Sutcliffe LLP

Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2021

This edition of Orrick’s series of life sciences publications breaks down the record venture investment into US-based life sciences companies in 2020 and strong showing in Q1 2021. Key findings include: • US-based life...more

Orrick, Herrington & Sutcliffe LLP

Life Sciences Snapshot - A Quarterly Report on Financing Trends - Q3 2020

In this edition of Orrick’s series of life sciences publications, the traditional update on broader venture market financing data is included, depicting the macro-level trends of interest. In addition, given their surge in...more

Orrick, Herrington & Sutcliffe LLP

Life Sciences Snapshot - A Quarterly Report on Financing Trends: Companies & Investors Navigate the Pandemic Era Q2 2020

In this edition of Orrick’s series of life sciences publications, we offer a market update drawing on a variety of PitchBook datasets depicting macro trends in financing across the market, as well as a spotlight on any trends...more

Orrick, Herrington & Sutcliffe LLP

Life Sciences Snapshot: A Quarterly Report on Financing Trends - Companies & Investors Navigate the Pandemic Era Q2 2020

In this edition of Orrick’s series of life sciences publications, we offer a market update drawing on a variety of PitchBook datasets depicting macro trends in financing across the market, as well as a spotlight on any trends...more

Orrick, Herrington & Sutcliffe LLP

Life Sciences Snapshot: A Quarterly Report on Financing Trends - THE MARKET MEETS COVID-19 Q1 2020

This first installment in a series of Orrick publications is dedicated to the exploration of trends in venture investment across life sciences. For this issue, we offer historical context to inform our trend analysis and...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Metacrine Secures $36 Million in Financing

McGuireWoods LLP on

Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies....more

Foley Hoag LLP

Venture Perspectives: Fourth Quarter 2014

Foley Hoag LLP on

The Numbers - Venture financing activity in New England increased modestly in the fourth quarter of 2014, with Seed and B/Later round activity increasing by 40% and 26%, respectively, over Q3 2014. For the second...more

Morrison & Foerster LLP

Royal Flush: Two Boulder financiers vow to make an impact in the life sciences field

Nate Hukill and Luke Düster first met in Shanghai, when the city was a boomtown with a skyline that was a forest of cranes. As college students studying abroad, they shared a small room, a tight budget—and a mischievous...more

Fenwick & West Life Sciences Group

Strategies For Navigating The Life Sciences Capital Crunch

The need for innovation in healthcare has arguably never been greater. Originally Published in Navigating The Capital Crunch - April 15, 2013. ...more

14 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide